In a small clinical study conducted in April and May 2020, British scientists investigated the effect of inhalation of nebulised interferon-beta-1a (SNG001) on the development of COVID-19 in patients. The results are encouraging and justify further research.
|Translated title of the contribution||Verneveld interferon als COVID-19 medicijn|
|Media of output||Online|
|Publication status||Published - 27 Dec 2020|